Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • 10 - Sleep and diabesity in older adults

  • from Part 2 - Neuroendocrine and homeostatic changes in the elderly
  • Edited by S. R. Pandi-Perumal, Jaime M. Monti, Universidad de la República, Uruguay, Andrew A. Monjan, National Institute on Aging, Bethesda, Maryland
  • Book:
    Principles and Practice of Geriatric Sleep Medicine
    Published online:
    04 August 2010
    Print publication:
    26 November 2009, pp 107-120

  • Summary

    This chapter examines the existing evidence relating reduced sleep duration and quality, as occurs in a majority of older adults, and the epidemic of diabesity. Blood levels of glucose are tightly regulated within a narrow range to avoid hypoglycemia and hyperglycemia as both conditions have serious adverse consequences. The release of growth hormone (GH) during early sleep contributes to prevent the decline of glucose levels. There is increasing evidence that age-related alterations in sleep quality may result in disturbances of endocrine function, raising the hypothesis that some of the hormonal and metabolic hallmarks of aging partly reflect the deterioration of sleep quality. Glucose regulation was assessed by intravenous glucose tolerance test (ivGTT) at the end of each of the two conditions, after two consecutive nights of undisturbed baseline sleep, and after three nights of suppression of slow wave sleep (SWS).